SCHEMBL6158653

SCHEMBL6158653

CC(C)Oc1cc(O)cc2nc[nH]c(=O)c12.CC(C)Oc1cc(OCc2ccccc2)cc2nc[nH]c(=O)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 3/20 0.49
MCL1 Q07820 1/20 0.40
GCK P35557 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP1A1 P04798 1/20 0.37
CYP19A1 P11511 1/20 0.37
MAOB P27338 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
PPARG P37231 2/20 0.37
NSD2 O96028 1/20 0.37
ABL1 P00519 1/20 0.37
RIN1 Q13671 1/20 0.37
NCOR2 Q9Y618 1/20 0.37
EDNRA P25101 1/20 0.37
IP6K3 Q96PC2 1/20 0.37
IP6K2 Q9UHH9 1/20 0.37
LMNA P02545 2/20 0.36
PTGS1 P23219 1/20 0.36
SLC6A2 P23975 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3198358 0.95 IP6K1 (0.54) IP6K1MCL1GCKMAOBL3MBTL1
SCHEMBL3204606 0.84 PARP1 (0.41)
SCHEMBL3275718 0.83 IP6K1 (0.61) IP6K1CYP1A2MAOBL3MBTL1PPARG
SCHEMBL29717416 0.83 IP6K1 (0.61) IP6K1CYP1A2MAOBL3MBTL1PPARG
SCHEMBL31728743 0.82 IP6K1 (0.57) IP6K1CYP1A2CYP1A1MAOBL3MBTL1
SCHEMBL29717506 0.81 IP6K1 (0.61) IP6K1MCL1CYP1A2CYP1A1CYP19A1
SCHEMBL3275884 0.81 IP6K1 (0.61) IP6K1MCL1CYP1A2CYP1A1CYP19A1
SCHEMBL23068614 0.78 PARP1 (0.39) IP6K1
SCHEMBL3193429 0.76 QPCT (0.39) IP6K1L3MBTL1LMNAMAPT
SCHEMBL4292544 0.76 KDM4E (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528925-A1 QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER Astrazeneca AB (SE) 2005-05-11 EP disclosed
WO-2004004732-A1 QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2004-01-15 WO disclosed